Evidence map›Paper›PMID 36696405›Full record

ArticlePloS one2023

SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control.

Oluwapelumi Olufemi Adeyemi, Nnaemeka Darlington Ndodo, Mariam Kehinde Sulaiman, Oyeronke Temidayo Ayansola, Oluwabunmi Idera Nimat Buhari, Olusola Anuoluwapo Akanbi, Oladimeji Akeem Bolarinwa, Chimaobi Chukwu, Ireoluwa Yinka Joel, Adesuyi Ayodeji Omoare and 20 more

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Oluwapelumi Olufemi AdeyemiDepartment of Medical Microbiology and Parasitology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID 0000-0002-0848-5917
Nnaemeka Darlington NdodoNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Mariam Kehinde SulaimanDepartment of Medical Microbiology and Parasitology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID 0000-0002-8295-7855
Oyeronke Temidayo AyansolaNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Oluwabunmi Idera Nimat BuhariDepartment of Behavioural Sciences, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Olusola Anuoluwapo AkanbiNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Oladimeji Akeem BolarinwaDepartment of Epidemiology and Community Health, Faculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Chimaobi ChukwuNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Ireoluwa Yinka JoelMolecular Diagnostic and Research Laboratory, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Adesuyi Ayodeji OmoareNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Kolawole Wasiu WahabDepartment of Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Celestina ObiekeaNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.ORCID 0000-0003-2355-5917
Mikhail Olayinka BuhariDepartment of Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Anthony AhumibeNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.ORCID 0000-0002-4651-4424
Caroline Folasade KolawoleHealth Services, University of Ilorin, Ilorin, Nigeria.
Catherine OkoiNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Olumuyiwa Babagbemi OmoteshoHealth Services, University of Ilorin, Ilorin, Nigeria.
Nwando MbaNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Oluwafemi AdeniyiHealth Services, University of Ilorin, Ilorin, Nigeria.
Olajumoke BabatundeNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Nathaniel AkintundeHealth Services, University of Ilorin, Ilorin, Nigeria.
Ganiu AyinlaHealth Services, University of Ilorin, Ilorin, Nigeria.
Oluwatosin Wuraola AkandeNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Rasheed Adekeye OdunolaHealth Services, University of Ilorin, Ilorin, Nigeria.
Mohammed Jimoh SakaDepartment of Epidemiology and Community Health, Faculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Omotosho Ibrahim MusaDepartment of Epidemiology and Community Health, Faculty of Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Idayat Adenike DurotoyeDepartment of Haematology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Chikwe IhekweazuNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Ifedayo Morayo AdetifaNational Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Nigeria.
Abayomi FadeyiDepartment of Medical Microbiology and Parasitology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.ORCID 0000-0002-0535-9296

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 global pandemic is being driven by evolving SARS-CoV-2 variants with consequential implications on virus transmissibility, host immunity, and disease severity. Continuous molecular and genomic surveillance of the SARS-CoV-2 variants is therefore necessary for public health interventions toward the management of the pandemic. This study is a retrospective analysis of COVID-19 cases reported in a Nigerian tertiary institution from July to December 2021. In total, 705 suspected COVID-19 cases that comprised 547 students and 158 non-students were investigated by real time PCR (RT-PCR); of which 372 (~52.8%) tested positive for COVID-19. Using a set of selection criteria, 74 (~19.9%) COVID-19 positive samples were selected for next generation sequencing. Data showed that there were two outbreaks of COVID-19 within the university community over the study period, during which more females (56.8%) tested positive than males (47.8%) (p<0.05). Clinical data together with phylogenetic analysis suggested community transmission of SARS-CoV-2 through mostly asymptomatic and/or pre-symptomatic individuals. Confirmed COVID-19 cases were mostly mild, however, SARS-CoV-2 delta (77%) and omicron (4.1%) variants were implicated as major drivers of respective waves of infections during the study period. This study highlights the importance of integrated surveillance of communicable disease during outbreaks.

Indexed as

COVID-19SARS-CoV-2Disease OutbreaksFemaleHumansMaleNigeriaPandemicsPhylogenyRetrospective Studies

Identifiers

PMID36696405
PMCPMC9876355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.